Our Expert Community
Co-Founder, Co-CEO A—I Company
Vera Cavalli graduated in Pharmacy at the University of Basel and is a founding partner and executive of Mymeleon INC., Palo Alto. Previously she was an engaged businesswoman, co-founder of the mondoBIOTECH company and widely recognised as someone striving for innovation in the field of rare diseases, using Search & Match technology to facilitate the discovery of new drugs. In 2009, Vera made mondoBIOTECH public on the Swiss Stock Exchange with a market capitalisation surpassing 2,4 billion Swiss francs. She then moved on in 2010 to create a foundation aimed at helping people affected by rare diseases, together with her husband Fabio.
Marie Louise Gloria
Head Experts Community
Marie Louise is a young professional who grew up between Italy and Portugal, later attending university in England. Her studies focused on Systems and Electrical Engineering courses at Loughborough University and the Politecnico of Torino. Italian and English are her mother tongues and she can also speak, at various levels, German, French and Portuguese. In her youth, she has played multiple sports at a competitive level: team based ones like football and basketball, as well as horse riding (eventing) and skiing. She loves traveling, poetry and writing. Her current fields of interest are nutrition and cooking as they are closely tied to her own personal experience.
Giuseppe Vercelli Team
Psychologist and psychotherapist, professor of Sport and Human Performance Psychology at the University of Turin.
Together with his team he conceived and developed the S.F.E.R.A. for the analysis and optimization of performance. He directs the Center for Psychology of Sport and Human Performance of the ISEF in Turin. Head of the Psychological Area of Juventus F.C. since 2011 and psychologist at J-Medical
Member of the medical commission and head of the psychological area of the FISI (Italian Winter Sports Federation), collaborates with FIBa (Italian Badminton Federation) and UITS (Italian Shooting Union). He participated in the Olympics in Turin, Beijing, Vancouver, London and PeyongChang as an official psychologist of CONI.
MD, MBBCH, GAICD, Super-expert. International health professional, medical doctor and corporate advisor
Dr Linda Friedland is a physician with over 25 years' experience in clinical medicine and an international advisor to many of Fortune and Forbes top global companies. She consults to healthcare, biotech, corporate and financial institutions. An author of seven books with a long career in health media she has developed public health and disease management programs in Asia, US, Australia, Africa and the UK and delivered addresses in more than 30 countries. She is an authority on executive and corporate health, women’s wellbeing as well as stress management and performance. She has a real passion for social impact and disease prevention globally.
MD, PhD, Full Professor of Clinical Pathology, Department of Translational Medicine, Federico II University of Naples
A summa cum laude graduate of Medicine and Surgery at the Federico II University of Naples in 1990, he obtains a PhD in Biology and Cellular and Molecular Pathology in 1995 at the University of Verona, followed by a Specialization in Endocrinology and Diseases of the Metabolism at the Federico II University of Naples in 1999. Between 1990 and 1992 he is Visiting Fellow at the Institute of Microbiology of the University of Copenhagen, and between 1993 and 1995, Fogarty Fellow at the Diabetes Branch of the National Institute of Health in Bethesda, Maryland, USA. In 1996 he becomes a University Researcher, in 2005 an Associate Professor and as of 2014 Full Professor of Clinical Pathology at the Department of Translational Medical Sciences at the Federico II University of Naples. In 2009 he is named Project Manager at the Institute of Endocrinology and Experimental Oncology at the National Research Council. In 1999 he serves as Medical Director of Clinical Pathology and in 2014 Head of the Advanced Endocrinological Diagnostics Program at the Federico II University Hospital. In 2018 he joins the National Scientific Qualification Commission for the Competition Sector of General Pathology and Clinical Pathology as a member. To date he has co-authored 160 scientific papers for international journals (H-Index 36). His main area of interest in research is the physiopathology of fat tissue, and the study of its interactions with other organs and tissues. In particular, he is focussed on how environmental factors (nutrition and pollutants) affect fat tissue and how the latter modulates local and systemic inflammatory signals, contributing to the onset and progression of metabolic, cardiovascular and neoplastic diseases.
Three-Michelin-starred chef, Scientific Director Campus University Principe of Naples
Today Heinz Beck is known as one of the most notable “Masters” of gastronomy in the world. Careful observer of food effects on the body, Heinz Beck has been carrying on for almost 20 years important cooperations with national and international scientists as well as Italian Universities concerning the good balance between food and health. His unique interpretation of the “Modern” kitchen includes the utmost attention toward the selection of healthy ingredients and their transformation into highly innovative flavors.
MBChB, MPhil (SEM), PhD, Head of Medical staff UAE Team Emirates
Professor Swart is a Sports Physician and Exercise Scientist based at the University of Cape Town and at the Sports Science Institute of South Africa where he is the Director of Sports and Exercise Medicine teaching, research and clinical services. He is a founding member and director of the Cape Sports Medicine Group, the largest provider of Clinical Sports Medicine services on the African Continent and which is also an International Sports Medicine Federation center of collaboration and affiliated post graduate teaching center for the University of Cape Town. He is one of 7 members of the International Sports Medicine Federation Global Scientific committee and is the chair of The South African Sports Confederation and Olympic Committee (SASCOC) Scientific commission. He is also the medical director for UAE Team Emirates World Tour Cycling.
Gian Paolo Turri
Engineer, Scientist, CEO, Customer-Centricity and Total-Innovation™ advocate
I have lived, innovated, created products, teams, networks, friendship, music, and much more from Japan to California, passing through Germany, the UK, Switzerland, and of course, Italy. I have worked with various roles for the Max Planck Institute in Munich, UCLA university as an assistant professor and researcher in California. Later, at the UK Atomic Energy Authority (UKAEA) in Oxford, at EPFL University in Switzerland, where I have also worked for Siemens, Helen of Troy, and Abbott Laboratories.
In all the roles and places where I have been, I brought my optimism, energy, and love for music and sports. I played in rock bands in Italy, the USA, the UK, and Switzerland, and I have enjoyed playing in multicultural volleyball and football teams all over the world.
Cardiologist, Sport Doctor, Nutritionist and Journalist
Catholic University of the Sacred Heart, Rome Italy, Former faculty at the University of California at San Diego, USA, Director of the Cardiac Rehabilitation Unit, Fondazione Policlinico A. Gemelli-IRCCS, Roma, Expert in, Cardiac Prevention, Rehabilitation, Sports Cardiology and Nutrition, Author of more than 200 peer reviewed publication, Editor in chief of the European textbook of Echocardiography, Associate editor of the European Heart Journal.
PhD CChem FRSC, CEO
Dr. Esteban Pombo-Villar is the Chief Executive Officer of TargImmune Therapeutics, a Swiss company developing novel targeted drugs that attack cancers directly and stimulate the immune system to recognize and eliminate the tumors. Dr. Pombo-Villar has over 30 years of experience in leading biopharmaceutical R&D, business development and alliance management. Previously he was Chief Operations Officer (COO) for Oxford BioTherapeutics, and a Member of their Boards of Directors. He was responsible for the development data and manufacturing activities of their lead antibody and antibody-drug conjugate projects and their collaboration projects.
Dr. M. Libutti is a board-certified specialist in oncological surgery at the Naples School of Oncology University Federico II°. As of 2006 he is the Scientific Coordinator of the ‘Naples Conferences’, which are centred on chronic low-grade inflammation as a driver of multiple diseases. His research interests vary from the molecular biology of nutrients, to the pathways of metabolism and nutrition. Dr. Libutti is currently the Scientific Coordinator of a 3-year program for the prevention of chronic inflammatory diseases and cancer.
Iñigo San Millán
Professor at the University of Colorado School of Medicine
Head of Training staff, he is also a professor at the University of Colorado School of Medicine where he does clinical and research work on cellular metabolism, especially with regards to diabetes, cardiometabolic diseases and cancer.
Landscape Architect LAND Founding Member, CEO & Creative Director
Andreas Kipar is a German landscape architect and lecturer in landscape architecture.
Following a gardener's apprenticeship Kipar studied landscape gardening at the University of GHS Essen (now the University of Duisburg-Essen) from 1980 to 1984, and then from 1989 to 1994, architecture at the Milan Polytechnic (TU Milan). With agronomist Giovanni Sala, in 1990 he founded the international architecture and planning office LAND (acronym of "Landscape Architecture Nature Development”) in Milan, which he heads to this day. LAND manages worldwide projects from Italy (Milan) with branches in Germany (Düsseldorf) and Switzerland (Lugano). From 1998 to 2009 Kipar taught landscape architecture at the University of Genoa. Since 2009, he has been teaching Public Space Design at the Milan Polytechnic. Guest lectures have taken him to numerous universities and colleges in Italy, Germany, France and the USA.
PrMD FRCP FACP FRCPath, Clinical Professor of Hematological Oncology at the Tufts University Medical School, Boston, MA, USA and at the University of Buckingham Medical School, Buckingham, UK
Tariq trained in medicine at St George’s Hospital in London, followed by postgraduate training at Imperial College London at the Hammersmith Hospital, London, and the University of Colorado School of Medicine, Denver. He has specialist credentials in internal medicine, medical oncology, hematology, and stem cell transplantation in the UK and USA. He has held senior clinical leadership roles in centers of excellence for the treatment of cancer, as well as positions of increasing seniority in pharmaceutical medicine, focusing on the interface between academia, clinical practice and industry. His current research activities are in the field of precision medicine in hematological malignancies. He is involved in humanitarian activities to co-ordinate cancer care in Africa since 2011, when he founded Alpine Oncology Foundation, a Swiss-registered cancer charity, in memory of his mother. He has published over 130 peer reviewed papers, 33 cancer text-book chapters and 13 cancer books. He is the recipient of several awards, including those from the UK Royal College of Physicians, UK Royal College of Pathologists, American College of Physicians, Swiss humanitarian groups and runner-up for the Highly Commendable British Medical Association (UK) Book Award.
PhD, MBA CEO
Andreas is General Partner at BioMed Partners, a Swiss based VC and board member of several European biotech companies. He is a senior executive leader with more than 20 years of experience in the pharmaceutical industry, including 12 years as a member of the F. Hoffmann-La Roche Pharma R&D Executive Leadership team. He was Head of Cardiovascular & Metabolism R&D (CVM) and member of the Roche / Genentech Portfolio Committee. Andreas was part of several successful product developments and market introductions. Before the integration of Genentech, Andreas was global Head of Clinical Research & Exploratory Development. He had a key role in the integration of the Roche and Genentech Development organizations and led subsequently Roche’s Early Development Department. Andreas holds a PhD in Pharmacology from the University of Basel, degrees In Pharmaceutical Medicine and was trained as a fellow at the Centre of Human Drug Research at the University Hospital of Leiden, Netherlands. He also holds an Executive MBA from IMD Lausanne.
Dr. Hans-Lothar Arth
Patent, trademark and design attorneys
Dr. Arth obtained his Doctorate in chemistry in 1997 and received an award for his scholarly achievements from the German Chemical Society. Dr. Arth specializes in chemistry, pharmacy, biotechnology, medicine, with a particular focus on organic, polymer, and enzymatic chemistry, asymmetric synthesis, drug development, pharmaceutically active agents, and oil and gas exploration. During the course of his Doctorate, Dr. Arth synthesised chiral derivatives of natural products, designed assays, and prepared enzymes such as aldolases. During his 15-months of post-doctoral work at the Ohio State University (Columbus, Ohio, U.S.A.), Dr. Arth was involved in synthesising of a new anti-cancer drug. Before founding his own patent law firm, Dr. Arth worked for one-and-a-half years with the pharmaceutical company Axxima Pharmaceuticals AG in Munich where he established their intellectual property department going on to represent the company at a financing round of approximately 40 million euros. In the last few years Dr. Arth supported a range of companies at initial public offerings and financial rounds, represented companies and evaluated IP-portfolios and scientific projects for investors. Furthermore Dr. Arth supported companies at an IP-strategic product development proceeding as well as overseeing the management of the IP-portfolio.
Microbiologist and molecular biologist
Dr. Jennifer Baltes received a diploma in human biology from the Medical Faculty at the University of Marburg and a PhD from the Medical Faculty at the University of Göttingen under supervision of Prof. Dr. von Figura. During her studies, she gained practical and theoretical knowledge in molecular biology, biochemistry, cell biology, microbiology, immunology and molecular biology. Due to her strong biomedical background, her focus professionally lies with the biotechnology/pharmaceutical industry. Dr. Baltes is responsible for the elaboration of patent applications, reply to office actions, appeals, applications for cancellations and actions for the declaration of nullity, and for expert’s reports in the areas of pharmacy, galenics, biotechnology and medical products.
Further Dr. Baltes advises domestic clients how to file international trademark and design patent applications, at the strategic product development, the identification of patent strategies as well as the destruction of granted patents, particularly in Europe.
Dr. Baltes is head of the Biology and Biotechnology Team at ABK.
Dr. Dianne Snowden
Microbiologist and molecular biologist
Dianne Snowden is a microbiologist and molecular biologist. She obtained her Doctorate in microbiology in 2000 from La Trobe University, Australia. During her doctorate Dr. Snowden worked on the characterization of an unidentified virus-like particle using a range of standard virological, biochemical and genomic investigations. Dr. Snowden has a broad background in microbiology, virology and molecular biology and has lectured in microbiology at Australian universities. Dr. Snowden specializes in biotechnology for both the medical and agricultural fields, DNA, RNA and gene technology, immunology, diagnostics and assay systems, antibiotics, vectors and expression systems. In addition, Dr. Snowden has worked for several years as a technical specialist for a large patent law firm in Japan. During this time she obtained valuable experience in the prosecution of biotechnology patents before the Japanese Patent Office.
Boo Geun Kim
Dr. Boo Geun Kim is a chemist. He obtained his B.S. and M.S. degree of industrial chemistry at the Hanyang University, Seoul, Korea. He visited chemistry diploma course at TU Berlin and obtained his doctorate in chemistry at Potsdam University. During his doctorate his research focused on organometal-induced stereoselective radical reaction and [3+2] cycloaddition of nitronates and their application for synthesis of ulosonic acids and carbohydrate C-analogues. He worked as a postdoc in a medicinal chemistry group at Leibniz-institute of molecular pharmacology (FMP) in Berlin. His research topic was development of new phosphatase inhibitor for treatment of acute myeloid leukemia. He has acquired experience in high-throughput screening (HTS), hit-to-lead optimization, validation by in vitro assays, high-throughput library synthesis by synthetic robot, synthetic automation and compound management. His scientific expertise focuses on organic chemistry, medicinal chemistry, pharmacy, organometallic chemistry and polymer chemistry. He speaks German, English and Korean fluently and has good knowledge of Japanese. Dr. Kim’s work focuses on international and European application, expert opinions and advising of clients in Asia.
Dr. Oliviana Călin studied Chemistry at the Ecole Nationale Supérieure de Chimie de Rennes (France) specializing in life science chemistry and technology involving organic chemistry, biochemistry and chemical engineering. Her studies within Federation Gay Lussac were awarded with a Novartis fellowship. In September 2009, she joined the group of Prof. Seeberger at the Max Planck Institute of Colloids and Interfaces, Berlin (Germany) as a Marie Curie fellow. Her research focused on asymmetric synthesis of rare sugars as a key step for the assembly of immunogenic glycoconjugates, as well as on the automated solid phase synthesis of oligosaccharides. She received her Ph.D degree in 2013 from Freie Universität, Berlin. She has gained industrial experience with Sanofi-Aventis Research and Development and Veolia Environment. Her scientific expertise comprises life science chemistry and technology and more specifically organic and organometallic chemistry, medicinal chemistry, asymmetric synthesis and oligosaccharide synthesis. Dr. Călin is a well-versed expert in saccharide chemistry and vaccines. Oliviana Călin speaks French, English and Romanian fluently and has good knowledge of German and Spanish.
Dipl.-Chem. Senada Duric studied chemistry at the Technical University of Tuzla, Bosnia and Herzegovina with emphasis on technical chemistry and process technology. Thereafter, she studied environment protection technology at the Technical University of Munich. Ms. Duric gained her experience in industry when working with a chemical engineering laboratory. She continued her career with a leading position in a company performing microbiological environment analysis. During that time, Ms. Duric developed her enthusiasm for patent matters and consequently she attended an intellectual property course at the University of Hagen in order to become a patent engineer. She joined ABK in June 2005. The scientific skills of Dipl.-Chem. Senada Duric comprise chemical engineering, inorganic chemistry, power industry, oil and gas exploration, environment protection technology, analytics and materials science. Linguistic proficiency: German, English, Serbo-Croatian, Russian.
Tianna Dauner is an attorney at law licensed in the State of Florida, U.S. and permitted to practice as such by the Bar Association of Munich, Germany. She obtained her Juris Doctorate in 2005. Mrs. Dauner specializes in commercial transactions, and advises companies on their licenses and intellectual property, particularly trademarks and copyrights. Before establishing her law practice full-time, Mrs. Dauner worked for White & Case LLP in Munich, and Fujitsu-Siemens. She also advises companies on compliance with regulatory authorities in the areas of Life Sciences, Finance, and Competition. Mrs. Dauner is a Visiting Professor of Law at the University of Munich (Ludwig-Maximilians-Universität) for Competition law.
M. Sc. Limin Siebert-Su studied food technology at the Shenyang Agricultur University, Shenyang, China and bioinformatics at the Ludwig Maximilian University of Munich as well as technology and biotechnology of food at the Technical University of Munich. During her diploma thesis she worked on alcoholic and thermal influences on emulsifying properties of egg yolk and protein-protein interactions. Mrs. Siebert-Su has a diploma and a M. Sc. in technology and biotechnology of food. Her scientific expertise comprises food science and cosmetics, especially process engineering, cosmetic formulations, bioprocess technology, microbiology, nutrition physiology, food chemistry as well as chemical analysis of cosmetics and food. She joined ABK in February 2008 and is training with ABK as a patent engineer. Linguistic proficiency: Chinese, German and English.
Kirstin Bettin studied information technology with an emphasis on RF technology at the Technical University Ilmenau in Germany. During her studies, Ms. Bettin attended an 8 month internship at the chip design company SICAN GmbH in Hannover developing a HDL implementation of boundary scan basic elements. After graduation in 1993, Ms. Bettin worked for several years at the Fraunhofer Institute for Integrated circuits in Erlangen in the field of chip design and developed application specific integrated circuits. Furthermore Ms. Bettin was responsible for the implementation of a database at the Institute and developed a customer specific database in Lotus Notes. After two and a half years living in San Diego, CA, USA, Ms. Bettin joined ABK as a patent engineer. Her technical specialist fields are information technology, digital circuit design, database technologies, RF technology, and automotive engineering.